Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation
A El-Osta, P Kantharidis, JR Zalcberg… - Molecular and cellular …, 2002 - Taylor & Francis
Overexpression of the human multidrug resistance gene 1 (MDR1) is a negative prognostic
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
[PDF][PDF] Precipitous Release of Methyl-CpG Binding
AP Wolffe, A El-Osta, P Kantharidis, JR Zalcberg - Citeseer
MATERIALS AND METHODS Cell culture and drug treatments. CEM cells were grown in
RPMI 1640 medium (Sigma) supplemented with 10% fetal calf serum (Trace), L-glutamine (2 …
RPMI 1640 medium (Sigma) supplemented with 10% fetal calf serum (Trace), L-glutamine (2 …
Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene ( MDR1 ) on …
A El-Osta, P Kantharidis, JR Zalcberg… - Molecular and Cellular …, 2002 - cir.nii.ac.jp
抄録< jats: title> ABSTRACT</jats: title>< jats: p> Overexpression of the human multidrug
resistance gene 1 (< jats: italic> MDR1</jats: italic>) is a negative prognostic factor in …
resistance gene 1 (< jats: italic> MDR1</jats: italic>) is a negative prognostic factor in …
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation
A El-Osta, P Kantharidis, JR Zalcberg… - … and Cellular Biology, 2002 - research.monash.edu
Overexpression of the human multidrug resistance gene 1 (MDR1) is a negative prognostic
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation
A El-Osta, P Kantharidis… - … and cellular biology, 2002 - pubmed.ncbi.nlm.nih.gov
Overexpression of the human multidrug resistance gene 1 (MDR1) is a negative prognostic
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
[PDF][PDF] Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation
A El-Osta, P Kantharidis, JR Zalcberg… - MOLECULAR AND …, 2002 - academia.edu
MATERIALS AND METHODS Cell culture and drug treatments. CEM cells were grown in
RPMI 1640 medium (Sigma) supplemented with 10% fetal calf serum (Trace), L-glutamine (2 …
RPMI 1640 medium (Sigma) supplemented with 10% fetal calf serum (Trace), L-glutamine (2 …
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
A El-Osta, P Kantharidis, JR Zalcberg… - Molecular and Cellular …, 2002 - europepmc.org
Overexpression of the human multidrug resistance gene 1 (MDR1) is a negative prognostic
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation
A El-Osta, P Kantharidis, JR Zalcberg… - Molecular and Cellular …, 2002 - Am Soc Microbiol
Overexpression of the human multidrug resistance gene 1 (MDR1) is a negative prognostic
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
[HTML][HTML] Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on …
A El-Osta, P Kantharidis, JR Zalcberg… - Molecular and Cellular …, 2002 - ncbi.nlm.nih.gov
Overexpression of the human multidrug resistance gene 1 (MDR1) is a negative prognostic
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
factor in leukemia. Despite intense efforts to characterize the gene at the molecular level …
[PDF][PDF] Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation
A El-Osta, P Kantharidis, JR Zalcberg… - MOLECULAR AND …, 2002 - researchgate.net
MATERIALS AND METHODS Cell culture and drug treatments. CEM cells were grown in
RPMI 1640 medium (Sigma) supplemented with 10% fetal calf serum (Trace), L-glutamine (2 …
RPMI 1640 medium (Sigma) supplemented with 10% fetal calf serum (Trace), L-glutamine (2 …